Sirolimus
Sirolimus is a prescription mTOR inhibitor, dispensed here as a 1mg capsule in a narrow range of situations. It is prescribed only when a licensed provider identifies a clear clinical indication, and with close monitoring and scheduled follow-up.
Pharmacy shipping: $20 added once per medication order.
About this treatment
Target a defined condition through mTOR signaling.
Sirolimus, also called rapamycin, changes signaling involved in cell growth and immune activity. It has established roles in specific medical conditions. An informed discussion starts with the condition being treated, the intended benefit and the monitoring that treatment requires.
A medicine that changes cell-growth signaling
Sirolimus inhibits mTOR, a signaling pathway involved in cell growth and responses to nutrients. It also suppresses aspects of immune activity. Those effects explain its use in preventing kidney-transplant rejection and treating lymphangioleiomyomatosis, or LAM, a rare lung disease. The clinical purpose depends on the condition, rather than on changing a pathway for its own sake.
Understand the benefit for the actual condition
In a controlled study of people with LAM and impaired lung function, sirolimus stabilized lung function during treatment. This is a concrete example of a disease-specific benefit. For a different use, ask which human evidence applies to your diagnosis and the exact capsule being considered, and which symptom or clinical measure would show whether it is helping.
Make monitoring part of the decision
Discuss blood counts, kidney function, cholesterol and any drug-level testing relevant to your care. Bring your full medicine and supplement list, since some antibiotics, antifungals and other drugs change sirolimus levels. Grapefruit can also interact. Report fever, new cough, mouth sores or poor wound healing promptly, and review planned surgery, vaccinations and pregnancy plans before treatment.
Research and product information
Approved oral sirolimus products are tablets and solution for specific indications; IAM lists a capsule, which should not be assumed interchangeable. Disease-specific findings do not establish a general anti-aging benefit. Immunosuppression brings serious infection and malignancy risks that require individual review.
- DailyMed: RAPAMUNE sirolimus prescribing information
- McCormack et al. Sirolimus for lymphangioleiomyomatosis: randomized MILES trial (2011)
Sources checked .
Your path to Sirolimus
Complete the assessment
Share your full medical history and the clinical question.
Provider review
A licensed provider confirms a clear indication before any prescription.
Care coordination
Your care team coordinates the prescription after provider approval.
About this treatment
What it is
An mTOR inhibitor, usually associated with transplant and specific dermatologic regimens. Its use here is selective and always tied to a defined clinical indication.
Who it's for
A small number of patients with a specific clinical need identified by a provider. It is not dispensed as a general wellness product.
Forms we dispense
Capsule 1mg
A licensed provider reviews your history and requests labs when clinically appropriate before prescribing.
Prescriptions are coordinated with our licensed US pharmacy partner, with dosing supplies included when needed.
We do not sell pharmaceuticals online. Every prescription comes after a full provider review.
